Human immunodeficiency virus type 1 group M protease in Cameroon: Genetic diversity and protease inhibitor mutational features

Journal of Clinical Microbiology

Volumn 40, Issue 3, 2002, Pages 837-845

  Fonjungo, Peter N ^a   Mpoudi, Eitel N ^a   Torimiro, Judith N ^a   Alemnji, George A ^a   Eno, Laura T ^a   Lyonga, Esther J ^a   Nkengasong, John N ^a   Lal, Renu B ^a   Rayfield, Mark ^a   Kalish, Marcia L ^a   Folks, Thomas M ^a   Pieniazek, Danuta ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; INDINAVIR; NELFINAVIR; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ARTICLE; CAMEROON; DRUG RESISTANCE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS STRAIN;

AMINO ACID SEQUENCE; DNA, VIRAL; DRUG RESISTANCE, VIRAL; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; VARIATION (GENETICS);

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036197586     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.3.837-845.2002     Document Type: Article

References (40)

1. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire
2. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility
3. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naïve patients
4. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses
5. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors
6. Fine characterization of the antigenic site within the flap region in the protease protein of HIV-1
7. Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G
8. Protease inhibitors: Resistance, cross-resistance, fitness and the choice of initial and salvage therapies
9. PHYLIP - Phylogeny interference package (version 3.2)
10. Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon
11. PCR amplification of HIV-1 proteinase sequences directly from lab isolates allows determination of five conserved domains
12. Mutations in retroviral genes associated with drug resistance
13. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
14. Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis
15. Evidence of a high frequency of HIV-1 subtype F infections in a heterosexual population in Buenos Aires, Argentina
16. Understanding the genetic diversity of HIV-1
17. Most env and gag subtype A H1V-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG
18. Optimal alignments in linear space
19. Genotypic subtypes of HIV-1 in Cameroon
20. Distribution of H1V-1 subtypes among HIV-seropositive patients in the interior of Cote d'Ivoire
21. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
22. Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates
23. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
24. Genetic diversity of HIV-1: The moving target
25. Introduction of HIV-2 and multiple HIV-1 subtypes to Lebanon
26. Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide
27. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1
28. Dual and recombinant infections: An integral part of the HIV-1 epidemic in Brazil
29. HIV-1 nomenclature proposal
30. Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe
31. The genetic data environment an expandable GUI for multiple sequence analysis
32. Various types of HIV mixed infections in Cameroon
33. High diversity of HIV-1 subtype F strains in Central Africa
34. Managing resistance to anti-HIV drugs: An important consideration for effective disease management
35. Catalytic efficiency and vitality of HIV-1 proteases from African viral subtypes
36. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment-naive patients
37. Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa
38. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States
39. Resistance to antiretroviral therapy among patients in Uganda
40. Phylogenetic analysis of protease and transmembrane region of HIV type 1 group O